nodes	percent_of_prediction	percent_of_DWPC	metapath
Proflavine—F2—vertebral column—psoriasis	0.677	0.692	CbGeAlD
Proflavine—F2—endothelium—psoriasis	0.301	0.308	CbGeAlD
Proflavine—F2—IL1 and megakaryotyces in obesity—ICAM1—psoriasis	0.00122	0.0554	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000953	0.0431	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IFNG—psoriasis	0.000931	0.0421	CbGpPWpGaD
Proflavine—F2—Hemostasis—SERPINB8—psoriasis	0.000889	0.0402	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000791	0.0358	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—NFKB1—psoriasis	0.000775	0.0351	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—CAT—psoriasis	0.000747	0.0338	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—CRP—psoriasis	0.000729	0.033	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—APOE—psoriasis	0.000713	0.0323	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL4—psoriasis	0.000686	0.031	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—ICAM1—psoriasis	0.00067	0.0303	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL20—psoriasis	0.000613	0.0277	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—HCAR2—psoriasis	0.000603	0.0273	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—CAT—psoriasis	0.000593	0.0268	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—CRP—psoriasis	0.000593	0.0268	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—ICAM1—psoriasis	0.000545	0.0246	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IFNG—psoriasis	0.00051	0.0231	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—CRP—psoriasis	0.000471	0.0213	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—ICAM1—psoriasis	0.000433	0.0196	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000431	0.0195	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000424	0.0192	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IFNG—psoriasis	0.000415	0.0188	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000411	0.0186	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—NFKB1—psoriasis	0.000345	0.0156	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—HCAR2—psoriasis	0.00034	0.0154	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000335	0.0152	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—TNF—psoriasis	0.00033	0.0149	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IFNG—psoriasis	0.000329	0.0149	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL20—psoriasis	0.000313	0.0142	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—HCAR2—psoriasis	0.000309	0.014	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—NFKB1—psoriasis	0.000274	0.0124	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TNF—psoriasis	0.000268	0.0121	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IL6—psoriasis	0.000266	0.012	CbGpPWpGaD
Proflavine—F2—Hemostasis—ITGAL—psoriasis	0.000258	0.0117	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TP53—psoriasis	0.000237	0.0107	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—REN—psoriasis	0.000231	0.0104	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL6—psoriasis	0.000217	0.0098	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—TNF—psoriasis	0.000213	0.00964	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—HCAR2—psoriasis	0.000183	0.00826	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCL20—psoriasis	0.000177	0.008	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000172	0.00779	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IL6—psoriasis	0.000172	0.00778	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCL8—psoriasis	0.000165	0.00748	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL20—psoriasis	0.000161	0.00727	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TAGAP—psoriasis	0.000158	0.00716	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—ACE—psoriasis	0.000144	0.00651	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000119	0.00539	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000111	0.00502	CbGpPWpGaD
Proflavine—F2—Hemostasis—NOS2—psoriasis	0.000106	0.00479	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL20—psoriasis	9.49e-05	0.00429	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—LEP—psoriasis	8.95e-05	0.00405	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCL8—psoriasis	8.45e-05	0.00382	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.42e-05	0.00381	CbGpPWpGaD
Proflavine—F2—Hemostasis—VEGFA—psoriasis	6.14e-05	0.00278	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—CXCL8—psoriasis	5.94e-05	0.00269	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—SOCS1—psoriasis	5.22e-05	0.00236	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—TYK2—psoriasis	4.98e-05	0.00225	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCL8—psoriasis	4.78e-05	0.00216	CbGpPWpGaD
Proflavine—F2—Hemostasis—TP53—psoriasis	4.64e-05	0.0021	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCL8—psoriasis	4.34e-05	0.00196	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—LEP—psoriasis	3.86e-05	0.00174	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—APOE—psoriasis	3.86e-05	0.00174	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NFKBIA—psoriasis	3.59e-05	0.00163	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TYK2—psoriasis	2.94e-05	0.00133	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCL8—psoriasis	2.56e-05	0.00116	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL6—psoriasis	2.44e-05	0.0011	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—JUN—psoriasis	2.38e-05	0.00108	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—NFKB1—psoriasis	2.29e-05	0.00104	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—VEGFA—psoriasis	2.08e-05	0.000941	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—STAT3—psoriasis	2.06e-05	0.000932	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TP53—psoriasis	1.57e-05	0.000711	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL6—psoriasis	1.44e-05	0.000651	CbGpPWpGaD
